Pharma may avoid worst-case drug pricing scenario as US elections deadlocked

Pharma may have avoided a worst case scenario amid the political upheavals in the US elections with the threat of tough drug price legislation lowered, with hawkish Democrats unlikely to win overall control of Congress.